Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Technologies Enabling Resilient Pharmaceutical Supply Chains

HealthcareTechnologies Enabling Resilient Pharmaceutical Supply Chains

AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network

RELEASE DATE
21-Jan-2025
REGION
Global
Deliverable Type
Technology Research
Research Code: DB13-01-00-00-00
SKU: HC_2025_1261
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2025_1261

Technologies Enabling Resilient Pharmaceutical Supply Chains
Published on: 21-Jan-2025 | SKU: HC_2025_1261

Need more details?
$4,950.00
DownloadLink
Request Sample
Add to Compare
Need more details?
Description

This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model.

The study answers the following questions:
What are some new challenges big pharma's supply chains must address today? How can emerging technologies help lead the way in transparency and resilience?
How do different technological solutions allow connectivity and communication among important pharmaceutical supply chain stakeholders?
Given the recent global economic shocks, what new technology application strategies can pharmaceutical companies deploy to make their supply chains more responsive and efficient?
How can managers implement supplier synergies with technology companies and pharmaceutical companies benefit from formulating a more solid and integrated model for the pharmaceutical industry's supply chain?
How do the funding, technical readiness, and strategic collaborations of key companies in this field influence the development and potential success of the pharmaceutical supply chain?

Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Technologies Enabling Resilient Pharmaceutical Supply Chains

Growth Opportunities Fuel the Growth Pipeline Engine™

Research Methodology

Scope of Analysis

Introduction

Segmentation

Growth Drivers

Growth Restraints

Manufacturers to Wholesalers

Wholesalers to Pharmacies

Pharmacies to Patients

Key Pharmaceutical Supply Chain Participants

Key Pharmaceutical Supply Chain Participants (continued)

Key Pharmaceutical Supply Chain Participants (continued)

Funding Analysis

Key Partnerships and Acquisitions, 2021–2024

Manufacturers to Wholesalers—Outlook

Wholesalers to Pharmacies—Outlook

Pharmacies to Patients—Outlook

Growth Opportunity 1: IoT-enabled Tracking and Monitoring

Growth Opportunity 1: IoT-enabled Tracking and Monitoring (continued)

Growth Opportunity 2: Blockchain for Enhanced Transparency and Traceability

Growth Opportunity 2: Blockchain for Enhanced Transparency and Traceability (continued)

Growth Opportunity 3: Data Analytics and AI-driven Decision-making

Growth Opportunity 3: Data Analytics and AI-driven Decision-making (continued)

Benefits and Impacts of Growth Opportunities

Next Steps

Legal Disclaimer

Request Sample
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts
Related Research
  1. Global Pharmaceutical Industry Outlook, 2023
    Release Date: 27-Mar-23
  2. Growth Opportunities in Supply Chain Automation
    Release Date: 16-Feb-24
  3. Game-changing Strategies of European Pharma Companies
    Release Date: 17-Jan-17
  4. Growth Insight—Role of AI in the Pharmaceutical Industry, Global, 2018–2022
    Release Date: 26-Sep-19
  5. Growth Opportunities and Business Models Driving Sustainability in Pharmaceuticals Industry
    Release Date: 9-Jan-24

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model. The study answers the following questions: What are some new challenges big pharma's supply chains must address today? How can emerging technologies help lead the way in transparency and resilience? How do different technological solutions allow connectivity and communication among important pharmaceutical supply chain stakeholders? Given the recent global economic shocks, what new technology application strategies can pharmaceutical companies deploy to make their supply chains more responsive and efficient? How can managers implement supplier synergies with technology companies and pharmaceutical companies benefit from formulating a more solid and integrated model for the pharmaceutical industry's supply chain? How do the funding, technical readiness, and strategic collaborations of key companies in this field influence the development and potential success of the pharmaceutical supply chain?
More Information
Deliverable Type Technology Research
Author Pooja Suresh
Industries Healthcare
No Index No
Is Prebook No
Podcast No
WIP Number DB13-01-00-00-00